Biotechnology

Zolgensma cures fatal infant paralysis with one dose—for $2.1 million. The drug works. The price is the disease. Can medicine survive its own miracles?

Your genome is 3.2 billion letters. One typo can kill you. CRISPR-Cas9 can fix it — but sometimes it edits the wrong word. The stakes couldn't be higher.

A 2 million dollar gene therapy seems obscene until you calculate lifetime care. Discover how the QALY framework proves a cure is the ultimate bargain.

Gilead's Hepatitis C cure made Wall Street nervous — because cures destroy recurring revenue. The brutal economics behind pharma's innovation incentives.

After $100 billion in quantum computing investments, scientists are now reverse-engineering nature's quantum tricks—from photosynthesis to avian navigation.

A hidden clause in international law lets governments copy patented drugs at 1% of originator prices. Here's why Thailand and Brazil used it — and the US never has.